Lanean...
Cardiotoxicity associated with trastuzumab in normal clinical practice
Objective: To evaluate the incidence of cardiotoxicity associated with treatment with trastuzumab in clinical practice by describing its characteristics, progress, and associated risk factors. Methods: Retrospective observational study of patients with HER2-positive breast cancer treated with trastu...
Gorde:
| Argitaratua izan da: | Farmacia Hospitalaria |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Sociedad Española de Farmacia Hospitalaria
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://www.redalyc.org/articulo.oa?id=365961791003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|